Heart rate variability and stroke or systemic embolism in patients with atrial fibrillation

被引:2
|
作者
Hammerle, Peter [1 ,2 ]
Aeschbacher, Stefanie [1 ]
Schlageter, Vincent [1 ]
Coslovsky, Michael [1 ,3 ]
Hennings, Elisa [1 ,2 ]
Krisai, Philipp [1 ,2 ]
Coduri, Federica [1 ]
Blum, Manuel R. [4 ,5 ]
Rodondi, Nicolas [4 ,5 ]
Reichlin, Tobias [6 ]
Muller, Andreas [7 ]
Stauber, Annina [7 ]
Moschovitis, Giorgio [8 ]
Rigamonti, Elia [8 ]
Beer, Jurg [9 ]
Ammann, Peter [10 ]
Bonati, Leo H. [11 ]
Conen, David [12 ,13 ]
Osswald, Stefan [1 ,2 ]
Kuhne, Michael [1 ,2 ]
Zuern, Christine S. [1 ,2 ]
机构
[1] Univ Basel, Univ Hosp Basel, Cardiovasc Res Inst Basel, Basel, Switzerland
[2] Univ Basel, Univ Hosp Basel, Dept Cardiol, Basel, Switzerland
[3] Univ Basel, Univ Hosp Basel, Dept Clin Res, Basel, Switzerland
[4] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland
[5] Univ Bern, Bern Univ Hosp, Dept Gen Internal Med, Inselspital, Bern, Switzerland
[6] Univ Bern, Bern Univ Hosp, Dept Cardiol, Inselspital, Bern, Switzerland
[7] Triemli Hosp Zurich, Dept Cardiol, Zurich, Switzerland
[8] Ente Osped Cantonale EOC, Reg Hosp Lugano, Cardioctr Ticino Inst, Div Cardiol, Lugano, Switzerland
[9] Univ Hosp Zurich, Cantonal Hosp Baden & Mol Cardiol, Dept Med, Zurich, Switzerland
[10] Kantonsspital St Gallen, Dept Cardiol, St Gallen, Switzerland
[11] Rheinfelden Rehabil Clin, Rheinfelden, Switzerland
[12] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada
[13] Hamilton Hlth Sci, Hamilton, ON, Canada
基金
瑞士国家科学基金会;
关键词
Atrial fibrillation; Stroke; Cardiac autonomic function; Heart rate variability; Electrocardiography; CARDIAC AUTONOMIC DERANGEMENT; ISCHEMIC-STROKE; WARFARIN; RISK; DYSFUNCTION; ARRHYTHMIAS; RHYTHM;
D O I
10.1016/j.hrthm.2024.05.028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Stroke remains one of the most serious complications in atrial fi brillation (AF) patients and has been linked to disturbances of the autonomic nervous system. OBJECTIVE The purpose of this study was to test the hypothesis that impaired cardiac autonomic function might be associated with an enhanced stroke risk in AF patients. METHODS A total of 1922 AF patients who were in either sinus rhythm (SR group; n = 1121) or AF (AF group; n = 801) on a 5minute resting electrocardiographic (ECG) recording were enrolled in the study. Heart rate variability triangular index (HRVI), standard deviation of normal-to-normal intervals, root mean square root of successive differences of normal-to-normal intervals, mean heart rate, 5-minute total power, and power in the high-frequency, low-frequency, and very-low-frequency ranges were calculated. Cox regression models were constructed to examine the association of heart rate variability (HRV) parameters with the composite endpoint of stroke or systemic embolism. RESULTS Mean age was 71 +/- 8 years in the SR group and 75 +/- 8 years in the AF group. Thirty-seven patients in the SR group (3.4%) and 60 patients in the AF group (8.0%) experienced a stroke or systemic embolism during follow-up of 5 years. In patients with SR, HRVI <15 was the strongest HRV parameter to be associated with stroke or systemic embolism (hazard ratio 3.04; 95% confidence fi dence interval 1.3-7.0; P = . 009) after adjustment for multiple confounders. In the AF group, no HRV parameter was found to be associated with the composite endpoint. CONCLUSION HRVI measured during SR on a single 5-minute ECG recording is independently associated with stroke or systemic embolism in AF patients. HRV analysis in SR may help to improve risk stratification fi cation in AF patients.
引用
收藏
页码:1509 / 1516
页数:8
相关论文
共 50 条
  • [1] Stroke and systemic embolism in patients with atrial fibrillation and heart failure according to heart failure type
    Uhm, Jae-Sun
    Kim, Jun
    Yu, Hee Tae
    Kim, Tae-Hoon
    Lee, So-Ryoung
    Cha, Myung-Jin
    Choi, Eue-Keun
    Lee, Jung Myung
    Kim, Jin-Bae
    Park, Junbeom
    Park, Jin-Kyu
    Kang, Ki-Woon
    Shim, Jaemin
    Park, Hyung Wook
    Lee, Young Soo
    Kim, Chang-Soo
    Mun, Ji Eun
    Son, Nak-Hoon
    Joung, Boyoung
    ESC HEART FAILURE, 2021, 8 (02): : 1582 - 1589
  • [3] Risk for stroke and systemic embolism in patients with atrial fibrillation and heart failure according to heart failure type
    Uhm, J. S.
    Yu, H. T.
    Kim, T. H.
    Pak, H. N.
    Lee, M. H.
    Joung, B.
    EUROPEAN HEART JOURNAL, 2020, 41 : 993 - 993
  • [4] The variability of the heart rate in patients with atrial fibrillation: Relationship with abnormalities of the haemostatic system and cerebral embolism
    Kirichuk, VF
    Shwartz, JG
    Sokolov, IM
    Kabanova, IA
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1251 - P1251
  • [5] Scattering Transform of Heart Rate Variability for the Prediction of Ischemic Stroke in Patients with Atrial Fibrillation
    Leonarduzzi, Roberto
    Abry, Patrice
    Wendt, Herwig
    Kiyono, Ken
    Yamamoto, Yoshiharu
    Watanabe, Eiichi
    Hayano, Junichiro
    METHODS OF INFORMATION IN MEDICINE, 2018, 57 (03) : 141 - 145
  • [6] Heart rate variability in patients with atrial fibrillation and hypertension
    Khan, Ahsan A.
    Junejo, Rehan T.
    Thomas, Graham N.
    Fisher, James P.
    Lip, Gregory Y. H.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 (01)
  • [7] Multiscale Entropy of the Heart Rate Variability for the Prediction of an Ischemic Stroke in Patients with Permanent Atrial Fibrillation
    Watanabe, Eiichi
    Kiyono, Ken
    Hayano, Junichiro
    Yamamoto, Yoshiharu
    Inamasu, Joji
    Yamamoto, Mayumi
    Ichikawa, Tomohide
    Sobue, Yoshihiro
    Harada, Masehide
    Ozaki, Yukio
    PLOS ONE, 2015, 10 (09):
  • [8] Preventing Stroke and Systemic Embolism in Renal Patients with Atrial Fibrillation: Focus on Anticoagulation
    Ahmad, Yousif
    Lip, Gregory Y. H.
    BRAIN, STROKE AND KIDNEY, 2013, 179 : 81 - 91
  • [9] Spotlight on Dabigatran Etexilate in the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation
    Garnock-Jones, Karly P.
    DRUGS & AGING, 2011, 28 (05) : 415 - 419
  • [10] Spotlight on Dabigatran Etexilate in the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation
    Karly P. Garnock-Jones
    Drugs & Aging, 2011, 28 : 415 - 419